Theranostic two-dimensional superparamagnetic maghemite quantum structures for ROS-mediated cancer therapy. Issue 29 (6th July 2021)

• Record Type: Journal Article
• Authors: Rehman, Yaser; Cheng, Zhenxiang; Wang, Xiaolin; Huang, Xu-Feng; Konstantinov, Konstantin
• Is Part Of: Journal of materials chemistry. Volume 9:Issue 29(2021)
• Page Start: 5805
• Page End: 5817
• Publication Date: 2021-07-06
• Subjects: Materials -- Periodicals; Chemistry, Analytic -- Periodicals; Biomedical materials -- Research -- Periodicals; 543.0284
• DOI: 10.1039/d1tb01036k
• Languages: English
• ISSNs: 2050-750X

Abstract

Abstract : In this work, size- and shape-controlled two-dimensional (2D) superparamagnetic maghemite (γ-Fe2 O3 ) quantum flakes (MQFs) with high surface area and mesoporosity were prepared by facile hydrothermal synthesis for biological applications. Abstract : In this work, size- and shape-controlled two-dimensional (2D) superparamagnetic maghemite (γ-Fe2 O3 ) quantum flakes (MQFs) with high surface area and mesoporosity were prepared by facile hydrothermal synthesis for biological applications. These quantum flakes exhibited superparamagnetic behaviours over a wide temperature range of 75–950 K with high saturation magnetization of M s – 23 emu g −1 and a lower coercivity of H c – 6.1 Oe. MQFs also demonstrated a good colloidal stability and a positively charged flake surface. Selective toxicity dependent upon selective ROS scavenging/generation and cellular MQF uptake towards non-malignant human keratinocyte (HaCaT) and malignant melanoma (A357) and human breast cancer (MDA-MB 231) cell lines were witnessed. An increased ROS concentration resulted due to the peroxidase-like activity of MQFs in malignant cells. In contrast, ROS scavenging was observed in non-malignant cells due to dominant catalase-like activity. In vitro fluorescence properties added the diagnostic ability to the ambit of MQFs. Furthermore, the therapeutic efficiency could be significantly enhanced by the hyperthermic (25–47 °C) ability of MQF in cancerous cells. Our findings reveal the novel theranostic MQF structure with immense cancer therapeutic potential via augmentation of ROS generation by hyperthermia in a selective microenvironment.